您的位置: 首页 > 农业专利 > 详情页

GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE
专利权人:
Siamab Therapeutics; Inc.
发明人:
David A. Eavarone,Jeffrey Behrens,Alexey Alexandrovich Lugovskoy
申请号:
US16462075
公开号:
US20190276541A1
申请日:
2017.11.17
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present disclosure provides antibodies with T cell-interacting regions and/or glycan-interacting regions. Bispecific antibodies capable of recruiting T cells to cancer cells are also provided, including bispecific antibodies capable of recruiting T cells to cancer cells expressing sialyl Tn (STn). The present disclosure also includes methods for killing cells by targeting them with antibodies having T cell-interacting regions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充